Announcement imminent

There are only seven business days left to the end of the month (30 August) when Benitec must report its Preliminary Final Report according to the ASX timetable for reporting in 2019. Looking over all other similar reports by the company over the last 10 years it will contain a very detailed and comprehensive description of the progress the company has made over the previous 12 months - pipeline, clinical developments, partnerships and even material events after the lodgement date.

There may be an announcement any day if the company wants to announce the pipeline before the report.

The question is is how will Benitec report OPMD progress if it is restricted by Axovant until September 3. Well it may not report OPMD for a further three days after the Preliminary Report is lodged which means we will have two very significant value catalysts in a matter of days to anticipate.

The company is cashed up (22 million), no debt, workforce reduced by 50%, and trading at half its cash value with zero enterprise value. It has also budgeted to complete OPMD through trials without raising more capital. Most other companies on the ASX are trading at 22 times their valuations and are about to fall after an extended bull run.


Now it’s Benitec’s turn to rise and run.